Baxter International Inc.

NYSE:BAX

Medical - Instruments & Supplies

Healthcare
$26.16 -5.23%

-$1.07 today

Market cap
$13.53B
Beta
0.64
P/E (TTM)
-9.1
EPS (TTM)
-$2.13
Dividend yield
1.03%
52W Low $15.73High $31.76

Volume 4.01M

Average 7.62M

BAX Depreciation & Amortization

Non-cash asset write-downs added back to net income because no cash left the business.

Baxter International Inc.NYSE: BAX

Depreciation & Amortization · Q2 FY2026 · quarter ended Jun 2026

Depreciation & amortization declines year over year

Q2 FY2026 depreciation & amortization of $239M fell 7.0% year over year, behind the -5.0% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 0.8% from the prior quarter. Over 3 fiscal years it compounded at -2.9% a year.

Context

  • Depreciation & amortization amounted to 8.7% of revenue in FY2025, down 0.6 pp from a year earlier.
  • Depreciation & amortization increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -7.0% toward the trailing-twelve-month pace of -5.0%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
$239M+0.8% QoQ
Last fiscal yearDec 2025
$981M-1.6% YoY
LTMJun 2026
$953M-5.0% YoY
Depreciation & Amortization past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-7.0%——
1 year-1.6%——
3-year CAGR-2.9%——
5-year CAGR——
10-year CAGR——

Depreciation & Amortization history

USD · from the cash flow

Latest · FY2025
981M USD
Year-over-year change
-1.6%
4-year CAGR
+3.1%

Depreciation & Amortization vs competitors

How BAX compares with its peers on the latest reported figures

  • Peers report in different currencies, so depreciation & amortization is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -5.0% is the lowest of 5, against a peer median of -0.9%.
  • Depreciation & amortization amounts to 8.3% of revenue for BAX, versus a peer median of 8.7%.
BAX Competitors
Depreciation & Amortization for BAX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
FMSFresenius Medical Care AG & Co. KGaALTM Jun 2026€1.56B EUR-3.5%-6.5%8.0%
BAXBaxter International Inc.LTM Jun 2026$953M USD-5.0%-2.9%8.3%
DVADaVita Inc.LTM Jun 2026$709.83M USD-0.3%-0.8%5.1%
ICUIICU Medical, Inc.LTM Jun 2026$204.78M USD-1.5%-5.1%9.5%
INFUInfuSystem Holdings, Inc.LTM Mar 2026$13.25M USD+2.4%-0.2%9.3%
Peer median (excluding BAX) —-0.9%-3.0%8.7%

Competitors are the stored peer set for BAX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income1.03B(3.11B)181M(326M)(957M)
Depreciation & Amortization867M1.07B984M997M981M
Deferred Income Tax(161M)(260M)(256M)(262M)77M
Stock-Based Compensation146M140M115M114M117M
Change in Working Capital(57M)(606M)161M(236M)(108M)
Accounts Receivables(170M)(48M)(38M)(35M)(132M)
Inventory(27M)(198M)(128M)(201M)(119M)
Accounts Payables105M(67M)92M112M3M
Other Working Capital35M(293M)235M(112M)140M
Other Non-Cash Items394M3.98B541M732M735M
Operating Cash Flow2.22B1.21B1.73B1.02B845M
Capital Expenditures(691M)(635M)(436M)(460M)(522M)
Acquisitions (Net)(10.5B)(263M)(6M)00
Purchases of Investments00000
Sales of Investments00034M0
Other Investing Activities(7M)(33M)3.66B(200M)3.35B
Investing Cash Flow(11.2B)(931M)3.21B(626M)2.84B
Debt Repayment9.33B(899M)(2.94B)(531M)(3.79B)
Common Stock Issued187M127M95M71M30M
Common Stock Repurchased(600M)(32M)000
Dividends Paid(530M)(573M)(586M)(590M)(348M)
Other Financing Activities(138M)(61M)(63M)(31M)(107M)
Financing Cash Flow8.25B(1.44B)(3.49B)(1.08B)(4.22B)
Effect of Forex Changes(47M)(76M)26M(96M)84M
Net Change in Cash(780M)(1.23B)1.48B(784M)(446M)
Free Cash Flow1.53B576M1.29B559M323M

Baxter International Inc.

NYSE:BAX

Intrinsic Alpha fair value

Locked

Current Price

$26.16

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.